CV Sciences, Inc. (CVSI): EPS (Basic)
-$0.01
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.01 | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$0.01 | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $0.02 | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$0.07 | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | -$0.14 | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$0.22 | n/m | 2022-04-04, From 2020-01-01 |
| 2019-12-31 | -$0.17 | n/m | 2020-03-30, From 2019-01-01 |
| 2018-12-31 | $0.11 | n/m | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$0.06 | n/a | 2019-03-12, From 2017-01-01 |
| No annual figure between 2015-12-31 and 2017-12-31. | |||
| 2015-12-31 | -$0.35 | n/m | 2016-04-14, From 2015-01-01 |
| 2014-12-31 | -$0.04 | n/m | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | -$0.23 | n/a | 2015-03-31, From 2013-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| CV Sciences, Inc. (CVSI) | 2025-12-31 | -$0.01 | n/m |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | -$1.28 | n/m |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | -$0.17 | n/m |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | -$0.80 | n/m |
| Palatin Technologies Inc (PTN) | 2026-06-30 | -$2.96 | n/m |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | -$14.57 | n/m |
| Evommune, Inc. (EVMN) | 2025-12-31 | -$11.22 | n/m |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | -$0.12 | n/m |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | -$1.29 | n/m |
Compare CVSI, PYXS, ABUS, IRD side by side · Screen every company in Pharmaceutical Preparations ↗